Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_59c085e4925ccb4e58765d070944bf3c |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D498-04 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D498-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
filingDate |
2017-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9f0b2c9210fccb79c2989da97a73e10a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_30852d00f9cd851f806457f00c45dd72 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a335aceb4f139e2eef7769a6d1d1bb31 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_149f490842fe4a0ca843979c1e0991fc |
publicationDate |
2017-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CN-107200748-A |
titleOfInvention |
fluorine-containing Dihydromyricetin derivative and its preparation method and application |
abstract |
The invention discloses a kind of fluorine-containing dihydromyricetin derivative or its pharmaceutically acceptable hydrate, including its stereoisomer or dynamic isomer.The fluorine-containing dihydromyricetin derivative of the present invention has AntiHIV1 RT activity and antitumaous effect, available for the purposes in treatment AntiHIV1 RT activity and cancer therapy drug.The invention discloses its preparation method. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108524489-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114507205-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114388857-A |
priorityDate |
2017-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |